PAXLOVID

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 1711bd830b29aa43
Drug Approval Canada Name: PAXLOVID
Product Name: PAXLOVID
Status: Marketed
Status Date: 2022-01-18
Original Market Date: 2022-01-18
Din: 02524031
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.48
Atc Original: J05AE30 NIRMATRELVIR AND RITONAVIR
Atc Name: j 05 ae 30
Aig Number: 0263338001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

RITONAVIR

100 MG

NIRMATRELVIR

150 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1711bd830b29aa43

Type

Standard